Cargando…
MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands
Opioids targeting mu;μ (MOP) receptors produce analgesia in the peri-operative period and palliative care. They also produce side effects including respiratory depression, tolerance/dependence and addiction. The N/OFQ opioid receptor (NOP) also produces analgesia but is devoid of the major MOP side...
Autores principales: | Bird, M. F., McDonald, J., Horley, B., O’Doherty, J. P., Fraser, B., Gibson, C. L., Guerrini, R., Caló, G., Lambert, D. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782398/ https://www.ncbi.nlm.nih.gov/pubmed/35061679 http://dx.doi.org/10.1371/journal.pone.0260880 |
Ejemplares similares
-
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)
por: Bird, Mark F., et al.
Publicado: (2016) -
In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells
por: Bird, Mark F., et al.
Publicado: (2022) -
Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor
por: Bird, M F, et al.
Publicado: (2018) -
Evaluation of [Cys(ATTO 488)(8)]Dermorphin-NH(2) as a novel tool for the study of μ-opioid peptide receptors
por: Giakomidi, Despina, et al.
Publicado: (2021) -
In vitro pharmacological characterization of a novel unbiased NOP receptor‐selective nonpeptide agonist AT‐403
por: Ferrari, Federica, et al.
Publicado: (2017)